| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/29/1999 | CN1230136A Process and device for separating magnetic materials from pharmaceutical compsns, their starting or intermediate products and agents produced by means of this device |
| 09/29/1999 | CN1229677A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/28/1999 | US5958881 Comprising peptide having amino acid sequence of vasoactive intestinal peptide; for inducing temporary substantial paralysis an area of interest in patients undergoing endoscopy or other medical procedure; side effect reduction |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/28/1999 | US5958718 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 09/28/1999 | US5958408 Glycosylation of lysin residue of a clearing agent which is an antibody or an antigen binding fragment of an antibody with a galactose residue for achieving fast clearance |
| 09/28/1999 | US5958376 Iodinated X-ray contrast media |
| 09/28/1999 | US5958375 Urea-linked, iodinated bis phenyl compounds for X-ray contrast media |
| 09/28/1999 | US5958373 Macrocyclic polyamine ligand forms a polychelate compound with lanthanides, chromium, iron and manganese; useful for diagnostic imaging contrast |
| 09/28/1999 | US5958372 Low viscosity chelating polymers for diagnostic imaging |
| 09/28/1999 | US5958371 Site specific binding system, nuclear imaging compositions and methods |
| 09/28/1999 | US5957848 Preparation of further diagnostic agents |
| 09/23/1999 | WO1999047940A1 MR METHODS FOR IMAGING PULMONARY AND CARDIAC VASCULATURE AND EVALUATING BLOOD FLOW USING DISSOLVED POLARIZED 129Xe |
| 09/23/1999 | WO1999047181A1 Hyperolius argus endocrine screen test |
| 09/23/1999 | WO1999039693A3 Methods and compositions for detection and diagnosis of infectious diseases |
| 09/22/1999 | EP0942915A1 Pharmaceutical formulations |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942757A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
| 09/22/1999 | EP0942756A2 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation) |
| 09/22/1999 | CN1228962A Composition and methods using nitroxides to avoid oxygen toxicity |
| 09/21/1999 | US5955601 Useful in nucleic acid hybridization assays and for generating labelled probes; unusually high efficiency of rare earth element capture correlated with emission of a high level of signal in time-resolved fluorescence spectroscopy |
| 09/21/1999 | US5955591 Phosphotriester oligonucleotides, amidites and method of preparation |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955490 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 09/21/1999 | US5955437 Use of an anticoagulant as a diagnostic agent |
| 09/21/1999 | US5955143 Hollow polymer microcapsules and method of producing the same |
| 09/21/1999 | US5955079 Composition comprising high molecular weight primary carrier, secondary carrier comprising t-dependent antigen conjugated to primary carrier, having enhanced antibody response to both carriers |
| 09/21/1999 | US5955056 Assay for monitoring and assessing the mutagenic potential of agents which involves creating transgenic non-human animals carrying a test dna sequence or sequences that can be quickly recovered and examined for mutations following exposure to one |
| 09/21/1999 | US5955055 Detection accumulated peptide with amino acid sequence region of apolipoprotein or elastin; labelling; diagnosing atherosclerosis |
| 09/21/1999 | US5954675 Methyl nicotinate swabbed onto the skin |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999045968A1 Manganese chelates with high relaxivity in serum |
| 09/16/1999 | WO1999045967A1 Manganese chelates with high relaxivity in serum |
| 09/16/1999 | WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 09/16/1999 | WO1999045936A1 Supercritical conditioned gas mixture containing co2, no and optionally a neutral gas |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2320936A1 Supercritical conditioned gas mixture containing co2, no and optionally a neutral gas |
| 09/15/1999 | EP0941129A1 Process for the production of iodinated organic x-ray contrast agents |
| 09/15/1999 | EP0941128A1 Echogenic coating containing gaseous spaces for ultrasonography |
| 09/15/1999 | EP0941127A2 Method |
| 09/15/1999 | EP0941126A1 Method of imaging |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0627942B1 Improvements in or relating to contrast agents |
| 09/15/1999 | CN1228762A Process for preparation of contrast agent |
| 09/14/1999 | US5951965 Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition |
| 09/14/1999 | US5951473 Determination of intracellular sodium and potassium ions by NMR |
| 09/14/1999 | CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof |
| 09/10/1999 | WO1999045016A2 Novel prodrugs for phosphorus-containing compounds |
| 09/10/1999 | WO1999044643A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 09/10/1999 | WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 09/09/1999 | DE19808865A1 Production of crosslinked structures of colloidal dimensions, e.g. hollow spheres or films, useful as lubricants, drug delivery systems, contrast agents, therapy vectors, chromatograhic media, magnetic data storage coatings, etc. |
| 09/09/1999 | DE19807475A1 New myxocheline derivatives useful e.g. for treating disorders associated with deficient metal ion metabolism, especially iron or aluminium metabolism, e.g. hemosiderosis, thalassemia or Alzheimer's disease |
| 09/09/1999 | DE19727740C1 Injection equipment introducing contrast medium into vessel, to display its internal structure by sonography - comprises needle or catheter with porous sintered tip, dispersing carbon dioxide bubbles into bloodstream |
| 09/08/1999 | EP0939653A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0939622A1 Porous microcapsules and their use as therapeutic and diagnostic vehicles |
| 09/08/1999 | EP0731797B1 Paramagnetic chelates for nuclear magnetic resonance diagnosis |
| 09/08/1999 | CN1228021A Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 09/07/1999 | US5948888 Neural thread protein gene expression and detection of Alzheimer's disease |
| 09/07/1999 | US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948634 Neural thread protein gene expression and detection of alzheimer's disease |
| 09/07/1999 | US5948387 Medical diagnosis |
| 09/07/1999 | US5948384 Particulate agents |
| 09/07/1999 | CA2050334C Iodinated non-ionic compounds, process for their preparation and contrast materials containing them |
| 09/02/1999 | WO1999043380A1 Gynecologic endovascular embolotherapy methods |
| 09/02/1999 | WO1999043345A1 Amino acid degrading enzymes modulate cell death |
| 09/02/1999 | WO1999024075A3 Affinity markers for human serum albumin |
| 09/02/1999 | WO1998040052A9 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/02/1999 | CA2318546A1 Gynecologic endovascular embolotherapy methods |
| 09/01/1999 | EP0938894A1 Implantable radiopaque device and use thereof |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938547A1 Modified ligands of calcium-dependent binding proteins |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | EP0938330A1 Use of lh-rh antagonists as diagnostic agent |
| 09/01/1999 | EP0938299A1 Methods for the production of protein particles useful for delivery of pharmacological agents |
| 09/01/1999 | EP0854855A4 Lipophilic contrast agents for use in hepatocyte-selective oil-in-water emulsions |
| 09/01/1999 | EP0782564B1 Iodinated x-ray contrast media |
| 09/01/1999 | EP0736035A4 Pretargeting methods and compounds |
| 09/01/1999 | CN1227562A Contrast agents |
| 09/01/1999 | CN1227502A Improvements in or relating to concrast agents |
| 09/01/1999 | CN1227498A 医用粉末 Medical powder |
| 08/31/1999 | US5945120 Gelified microspheres, their method of preparation and their applications |
| 08/26/1999 | WO1999042606A1 Methods of screening agents for activity using teleosts |
| 08/26/1999 | WO1999042435A2 Myxochelines |
| 08/26/1999 | WO1999042139A2 Hydroxyethyl starch conjugate, method for the production thereof and pharmaceuticals containing the same |
| 08/26/1999 | WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | WO1999035133A3 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 08/26/1999 | WO1999025389A9 Magnetic resonance imaging agents for the detection of physiological agents |
| 08/26/1999 | WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/26/1999 | DE19808079A1 New hydroxyethyl starch conjugates useful as X-ray, NMR and blood-pool diagnostic agents, e.g. for diagnosis of tumors, cardiovascular disorders and inflammation |
| 08/26/1999 | CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/25/1999 | EP0937460A2 Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions |
| 08/25/1999 | EP0937137A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 08/25/1999 | CN1226837A Steroids as neurochemical stimulators of VNO to alleviate symptoms of PMS and anxiety |
| 08/25/1999 | CN1226836A Polymer-lipid microencapsulated gases for use as imaging agents |
| 08/24/1999 | CA2075895C Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
| 08/19/1999 | WO1999040899A1 Implantable device and use thereof |
| 08/19/1999 | WO1999024394A3 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/19/1999 | WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents |